EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2025 Earnings Call Transcript March 4, 2026
EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.81426 EPS, expectations were $-0.78.
Operator: Good morning. My name is Michelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals, Inc. Fourth Quarter 2025 Financial Results and Recent Corporate Development Conference Call. There will be a...
